|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.720 SEK | +3.32% |
|
-3.96% | -35.41% |
| 07-07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 07-01 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 96.54M 10.02M 8.76M 8.1M 7.48M 14.08M 963M 14.34M 37.88M 471M 37.64M 36.81M 1.62B | P/E 2026 * |
-2.85x | P/E 2027 * | -2.08x |
|---|---|---|---|---|---|
| Enterprise Value | 88.54M 9.19M 8.03M 7.42M 6.86M 12.92M 883M 13.15M 34.74M 432M 34.52M 33.76M 1.49B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | +3.32% | ||
| 1 week | -3.96% | ||
| Current month | +2.59% | ||
| 1 month | +0.69% | ||
| 3 months | +6.60% | ||
| 6 months | -16.63% | ||
| Current year | -35.41% |
| 1 week | 8.25 |  | 9.07 |
| 1 month | 8 | | 9.8 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 31.9 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 319 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 2023-01-22 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 2026-06-30 |
| Chief Tech/Sci/R&D Officer | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 2022-05-24 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 2019-09-25 |
Pål Ryfors
BRD | Director/Board Member | 43 | 2022-05-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22-03-24 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 22-03-23 | Others | Chairman | 120,000 | 0.0268% | ||
| 21-12-19 | Free | Chief Financial Officer | 1,350,000 | 0.3011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.32% | -3.96% | -62.25% | -67.64% | 9.65M | |
| -2.48% | -6.72% | +44.19% | +156.43% | 1,054B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 621B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 438B | |
| -1.12% | -3.68% | +26.89% | +20.58% | 325B | |
| -1.73% | -3.45% | +26.95% | +44.09% | 281B | |
| -1.95% | -13.92% | +15.96% | +19.76% | 262B | |
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 195B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 163B | |
| Average | -0.78% | -3.80% | +14.92% | +39.68% | 355.62B | |
| Weighted average by Cap. | -0.90% | -4.77% | +33.16% | +77.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.22M -2.81M -2.6M -2.4M -4.52M -309M -4.6M -12.16M -151M -12.09M -11.82M -521M | -46M -4.77M -4.17M -3.86M -3.56M -6.71M -459M -6.83M -18.05M -225M -17.93M -17.54M -773M |
| Net Debt | -8M -830K -726K -671K -620K -1.17M -79.76M -1.19M -3.14M -39.06M -3.12M -3.05M -134M | -10M -1.04M -907K -839K -775K -1.46M -99.7M -1.49M -3.92M -48.82M -3.9M -3.81M -168M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | SEK 8.720 | +3.32% | 4,907 |
| 26-07-13 | SEK 8.440 | -0.12% | 13,974 |
| 26-07-10 | SEK 8.450 | -1.63% | 5,552 |
| 26-07-09 | SEK 8.590 | -2.61% | 16,750 |
| 26-07-08 | SEK 8.820 | -2.86% | 10,160 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
